ATTR-CM in Patients With Clinically Significant Plasma Cell Dyscrasias
Bhavya Ancha, Emily Brown, Mark Ranek, Nicole Lollo, Carol Ann Huff, Syed Abbas Ali, Christian B. Gocke, Phillip Imus, Claire Brookmeyer, Charles Steenbergen, Michael Polydefkis, Joban Vaishnav · 2026
Read ATTR-CM in Patients With Clinically Significant Plasma Cell Dyscrasias by Bhavya Ancha, Emily Brown, Mark Ranek, Nicole Lollo, Carol Ann Huff, Syed Abbas Ali, Christian B. Gocke, Phillip Imus, Claire Brookmeyer, Charles Steenbergen, Michael Polydefkis, Joban Vaishnav (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616544.txt.
Description
Bhavya Ancha and co-authors present six patients in whom two kinds of heart amyloid disease overlapped, in work from 2026. Amyloid stiffens the heart when faulty proteins pile up in it. One kind comes from blood cell disorders, the other from a transport protein gone rogue. Telling them apart changes treatment.
All six patients had clear blood cell disorders, which tempts doctors to assume the blood kind. Gene tests and heart tissue samples showed the transport kind instead, in both inherited and age-related forms. The series warns against the easy assumption. Tissue proof is needed to name the kind, and gene tests sharpen the guess when biopsy is delayed.
Catalog record
| CREATOR | Bhavya Ancha, Emily Brown, Mark Ranek, Nicole Lollo, Carol Ann Huff, Syed Abbas Ali, Christian B. Gocke, Phillip Imus, Claire Brookmeyer, Charles Steenbergen, Michael Polydefkis, Joban Vaishnav |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |